Tactiva Therapeutics Inc. logo

Tactiva Therapeutics Inc.

Tactiva Therapeutics is an immuno-oncology startup developing next generation adoptive cell therapy (ACT) strategies that deliver lethal hits to cancer cells by infusing large numbers of patients own T cells that have been re-programed to recognize, attack and destroy cancer cells.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://tactivatherapeutics.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
701 Seneca Street Suite 750, New York 14210
Buffalo
United States
Email
Contact Number
+1 7165362971

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/tactiva-therapeutics-inc.” connections=”true” suffix=””]

Tactiva Therapeutics novel autologous cellular immunotherapy is built on a dual enhanced adoptive cell therapy (DEACT_) platform, the companys engineered CD4/CD8 cells generate a durable supply of CD4 cells with direct anti-tumor activity as well as sustained helper function to CD8 T cell derived TCR-transduced effector T cells.